Evidence map›Paper›PMID 33466849›Full record

ReviewMolecules (Basel, Switzerland)2021

Beneficial Effects of Epigallocatechin-3-

Ryuuta Fukutomi, Tomokazu Ohishi, Yu Koyama, Monira Pervin, Yoriyuki Nakamura, Mamoru Isemura

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Exploring the Neuroprotective Potential ofPlants (Basel, Switzerland) · 2024
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. The Flavonoid Rich Black Currant (Molecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ryuuta FukutomiQuality Management Division, Higuchi Inc. Minato-ku, Tokyo 108-0075, Japan.ORCID 0000-0002-3918-5159
Tomokazu OhishiInstitute of Microbial Chemistry (BIKAKEN), Microbial Chemistry Research Foundation, Numazu, Shizuoka 410-0301, Japan.ORCID 0000-0002-9039-4474
Yu KoyamaShizuoka Eiwa Gakuin University Junior College, Suruga-ku, Shizuoka 422-8545, Japan.
Monira PervinTea Science Research Center, University of Shizuoka, Suruga-ku, Shizuoka 422-8526, Japan.
Yoriyuki NakamuraTea Science Research Center, University of Shizuoka, Suruga-ku, Shizuoka 422-8526, Japan.
Mamoru IsemuraTea Science Research Center, University of Shizuoka, Suruga-ku, Shizuoka 422-8526, Japan.ORCID 0000-0002-2965-1742
University of Shizuoka · JPMicrobial Chemistry Research Foundation · JPShizuoka Eiwa Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many observational and clinical studies have shown that consumption of diets rich in plant polyphenols have beneficial effects on various diseases such as cancer, obesity, diabetes, cardiovascular diseases, and neurodegenerative diseases (NDDs). Animal and cellular studies have indicated that these polyphenolic compounds contribute to such effects. The representative polyphenols are epigallocatechin-3-

Indexed as

AnimalsAntineoplastic AgentsAntioxidantsCatechinChlorogenic AcidCurcuminHumansNeurodegenerative DiseasesNeuroprotective AgentsResveratrolAntineoplastic AgentsAntioxidantsCatechinChlorogenic AcidCurcuminepigallocatechin gallateNeuroprotective AgentsResveratrolAMPKchlorogenic acidcurcuminEGCGNDDNF-κBpolyphenolsresveratrolROS

Identifiers

PMID33466849
PMCPMC7829779
OpenAlexW3118628487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.